KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cineverse (CNVS) Common Equity (2016 - 2025)

Historic Common Equity for Cineverse (CNVS) over the last 17 years, with Q4 2025 value amounting to $38.6 million.

  • Cineverse's Common Equity rose 303.77% to $38.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $38.6 million, marking a year-over-year increase of 303.77%. This contributed to the annual value of $38.8 million for FY2025, which is 1646.68% up from last year.
  • Per Cineverse's latest filing, its Common Equity stood at $38.6 million for Q4 2025, which was up 303.77% from $38.0 million recorded in Q3 2025.
  • Cineverse's Common Equity's 5-year high stood at $47.1 million during Q3 2023, with a 5-year trough of $17.2 million in Q1 2021.
  • Over the past 5 years, Cineverse's median Common Equity value was $37.7 million (recorded in 2024), while the average stood at $36.4 million.
  • Its Common Equity has fluctuated over the past 5 years, first skyrocketed by 108762.89% in 2021, then crashed by 3670.96% in 2024.
  • Over the past 5 years, Cineverse's Common Equity (Quarter) stood at $42.4 million in 2021, then dropped by 8.21% to $38.9 million in 2022, then increased by 14.35% to $44.5 million in 2023, then dropped by 15.88% to $37.4 million in 2024, then grew by 3.04% to $38.6 million in 2025.
  • Its Common Equity stands at $38.6 million for Q4 2025, versus $38.0 million for Q3 2025 and $37.1 million for Q2 2025.